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Abstract 
Synthetic cannabinoid receptor agonists (SCRAs), colloquially known as “spice,” are 
commonly used in prisons and enter establishments via the mail in the form of infused papers. 
Many prisons use benchtop Ion Mobility Spectroscopy (IMS) instruments to screen mail and 
seized materials for the presence of SCRAs and other controlled substances. The selectivity 
and sensitivity of Rapiscan Itemiser® 3E and Itemiser® 4DN ion trap mobility spectrometerTM 
(ITMSTM) systems were evaluated using 21 different SCRA reference standards. Some 
differences in the SCRA reduced mobility (K0) values were observed between this study and 
those reported previously using IMS detection systems, particularly for cumyl and quinolinyl 
SCRAs (e.g. 5F-PB-22, Cumyl-4CN-BINACA, and 5F-Cumyl-PEGACLONE) although this 
was found to have little effect at an operational level. Operational reliability of the systems was 
evaluated by analyzing 392 paper and card samples with known drug content. ITMSTM system 
results (e.g. detect or non-detect) were in agreement with gas chromatography-mass 
spectrometry (GC-MS) analysis in up to 95% of samples tested. Overall, this study found the 
ITMSTM systems tested to be effective instruments when deployed for the rapid detection of 
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SCRA infused papers. Used effectively and with up to date substance libraries, they will help 
reduce the supply of SCRAs into prisons and identify emerging threats as they arise. Several 
emerging SCRAs (5F-MPP-PICA, 5F-EMB-PICA, and 4F-MDMB-BICA) were detected for 
the first time in Scottish prisons between May and August 2020 as a result of routine monitoring 
and all were detected using the ITMSTM systems tested. 
 
1. Introduction 
Drug use in prisons is one of the greatest challenges facing the criminal justice system with 
studies in countries throughout the world finding higher rates of lifetime drug use, injecting 
drug use, and problematic drug use in prisoners than in the general population1. However, 
prisons have provided a setting for some prisoners to stop their drug use. In the last decade, the 
emergence and wide availability of new psychoactive substances (NPS) in prisons, mainly 
synthetic cannabinoid receptor agonists (SCRAs), colloquially known as “spice,” has made the 
attainment of that goal even more difficult2.  
 
SCRAs are a structurally diverse class of NPS3,4, varying widely in potency and efficacy as a 
result of differences in their chemical structures and structural conformation4–8. The SCRAs 
available on the illicit market change regularly in response to a number of factors including the 
implementation of national and international legislative controls to restrict their production, 
prevalence, and use; the increased online availability of published research studies and patents 
documenting their synthesis, in vitro potency and efficacy, and biological effects; the 
availability of precursor materials; and, possibly, in response to an increasing understanding of 
their structure-activity relationships by producers and suppliers4. Currently, the most 
commonly detected SCRAs in Scottish prisons are the tert-leucine methyl ester derived indole- 
or indazole-3-carboxamide SCRAs, 5F-MDMB-PICA (5F-MDMB-2201) (1), 4F-MDMB-
BINACA (2), and MDMB-4en-PINACA (3)9. The structures of SCRAs mentioned in the text 
are provided in Figure 1 and are denoted by a bold number in parentheses referring to the 
numbering shown in Figure 1. 
 
According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 22 
European countries have reported NPS use, and particularly SCRA use, in prisons, with 
concerning use reported in nine countries including the UK10. In prisons in England and Wales, 
it has been estimated that 60-90% of prisoners have used SCRAs2. Such high prevalence has 
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resulted in increasing levels of disruption, violence, and crime, and has had a negative impact 
on prisoner safety, rehabilitation, and recovery11-15. 
 
In the UK, with the exception of rough-sleeping communities in England and Wales, SCRAs 
appear to be currently used almost exclusively in prisons, indicating that they might serve 
specific prison-related functions not relevant to life in the community16,17. A 2019 study in 
England, using data from interviews conducted between 2017 and 2018, found that SCRAs are 
replacing traditional drugs in prisons due to their perceived ease of supply as a result of their 
high potency, which requires smaller doses than traditional drugs, and are therefore able to be 
infused into paper, clothing, and other materials17. 
 
In order to reduce drug use by prisoners, most prisons use a combination of demand and supply 
reduction measures. Demand reduction measures include mandatory drug testing (MDT), now 
including testing for SCRAs and their metabolites, and drugs rehabilitation programs. Supply 
reduction measures include extra perimeter defenses, body searches, and mail scanning. Most 
evidence suggests that the lack of drug availability in prisons is largely responsible for the 
reduction in the drug use of prisoners17, indicating that methods for the reduction of drug supply 
may be more effective. This is likely true for SCRAs since their easy availability in prisons is 
one of the most commonly stated reasons for their use18 and is borne out, in Scotland at least, 
by the fact that SCRA use rarely continues once a prisoner is released17. 
 
SCRAs largely enter prisons via the mail system on impregnated papers or card. Within the 
EU, SCRA-infused letters have been reported in Finland, Germany, Hungary, Lithuania, 
Poland, and Sweden, as well as outside the EU in the UK9,17,19,20and the United States21–23. It 
was recognized several years ago that the development of new easy to use, sensitive, and 
specific screening methods, or re-purposing of existing technology, to detect SCRAs on mail 
was urgently required20. In some countries, prisons have adjusted their mail regulations to try 
to limit the supply of SCRAs10, 24. This has introduced some concerns about the legality of 
opening prisoner mail. In Scotland, according to the Prison and Young Offenders Institutions 
(Scotland) Rules 2011, an officer or employee of SPS may prevent mail from being received 
by the prisoner if it is found to contain anything deemed restricted by the Scottish Ministers25. 
Those supplying SCRAs have attempted to circumvent this security measure by disguising the 
infused letters as legally privileged mail, often referred to as “Rule 39” mail in England and 
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Wales24 or simply as “Legal Mail” in Scotland25, which cannot be opened or read by prison 
staff24,25.  
 
Ion mobility spectrometers (IMS) and other rapid detection devices are established tools for 
the screening and preliminary identification of unknown substances in a security context26–29, 
particularly for the detection of trace levels of explosives and drugs within airports30. Analytes 
are introduced into the instrument on a sampling device (referred to as a sample trap) and are 
volatilized in a heated ionization chamber. Substances present form charged analyte ions. 
Ionization of neutral analytes, such as SCRAs, occurs via ion-molecule reactions to form 
protonated product ions, e.g. [M+H]+, and may be enhanced by the presence of dopants which 
can suppress the ionization of non-target molecules (ammonia, nicotinamide, and ammonium 
carbamate are commonly used for the analysis of drugs in positive ionization mode). The ions 
and ion clusters formed in the ionization chamber are separated based on their behavior in an 
ion drift region (also known as a drift/flight tube). The rate at which ions cross the ion drift 
region is inversely proportional to the size, shape, and mass of the ion31,32.  
 
A number of different IMS instrument designs are available with a range of sample introduction 
interfaces, ionization sources, detectors, and proprietary compound identification algorithms 
being employed29. Most stand-alone benchtop systems use thermal desorption for sample 
introduction with -particle emitting 63Ni, and corona discharge (CD) ionization sources or 
photoionization (PI) sources using an automated calibrating UV lamp providing a stable 
intensity/ionization energy. There are a number of drift tube designs and in this study, Ion Trap 
Mobility SpectroscopyTM (ITMSTM) is used. ITMSTM allows the simultaneous detection of 
positive and negative ions (although almost all SCRAs, and in fact most drugs, are detected in 
positive ion mode), and uses ion detectors based on Faraday plates33.   
 
IMS is one of several methods recommended by the United Nations Office on Drugs and Crime 
(UNODC) for the detection of SCRAs in seized materials34. Five studies on the detection of 
SCRAs using IMS instruments have been published, and to date all have used Smiths Detection 
IONSCAN instruments. All reported IMS to be a fast, easy to use, and highly sensitive 




This article is protected by copyright. All rights reserved. 
One of the limitations of IMS is that compounds with similar masses and structures cannot 
always be differentiated from one another34 but operationally this is less important as such 
instruments are used in a presumptive/screening mode rather than in an evidential context. In 
fact, this can also be viewed as a benefit of the use of such systems for the detection of SCRAs. 
If all SCRAs behave in a similar manner in the instrument, thereby giving a similar range of 
drift times, the potential for false positives or for missing new SCRAs as they emerge on the 
illicit market is minimized. New SCRA compounds are often close analogues of compounds 
already on the market (e.g. 1-4), so it is likely that IMS devices could still be able to detect new 
compounds based on the drift times and spectra of similar compounds in the library. In addition, 
the detection of new SCRAs appearing in prisons can be improved with the appropriate training 
of staff to recognize peaks that, while not alarming against a compound in the library, are within 
or close to the known drift time window for previously identified SCRA compounds. Samples 
producing such results can then be prioritized for confirmatory laboratory-based testing with 
more selective analytical techniques such as Gas Chromatography-Mass Spectrometry (GC-
MS) and Ultra Performance Liquid Chromatography with Quadrupole Time of Flight Mass 
Spectrometry (UPLC-QTOF-MS). 
 
This study evaluates the use of two ITMS instruments, the Rapiscan Itemiser® 3E, which 
uses a sealed 63Ni ionization source, and the Rapiscan Itemiser® 4DN, which uses a 
photoionization-based source and more advance proprietary detection algorithms, for the 
detection of SCRAs on infused papers. The instruments were evaluated in an operationally 
valid manner utilizing the same substance detection libraries used by non-scientifically trained 
front-line staff in prison settings. To determine system selectivity, sensitivity, and adaptability 
to emerging drug threats, a range of SCRA reference materials representing historical SCRAs 
that have not been detected in Scottish prisons since large-scale SCRA monitoring started in 
2018, currently prevalent SCRAs, and a number of emerging/prophetic compounds of a variety 
of structural classes, which might be expected to be detected in samples seized in future, were 
tested. In this study, 392 non-judicial paper samples seized from four Scottish prisons between 
June 2018 and December 2019, previously analyzed for the presence of SCRAs using GC-MS, 
are used as a ground truth dataset to robustly investigate the utility of IMS instruments for the 
screening of prison mail and other items for current and emerging SCRAs. More recently seized 
samples (recovered between May and August 2020) are used to assess the detection of newly 
emerging SCRAs. 
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2. Materials and Methods 
2.1. Materials 
Methanol and acetonitrile were HPLC grade (≥ 99.9% purity) and supplied by either Fisher 
Chemicals, UK or VWR Chemicals, UK. 
 
2.2. Seized Samples 
The “ground truth” samples used in this study were non-judicial or non-attributable samples 
seized by the Scottish Prison Service from four prisons between June 2018 and December 2019. 
Some samples were seized from prisoners directly, as a result of personal or cell searches, or 
were identified during screening of incoming mail items using the same Rapiscan Itemiser® 3E 
ITMSTM systems used in this study in-situ. Immediately after seizure, samples were placed into 
labelled tamperproof polythene evidence bags, sealed, and stored securely, with visually 
distinct papers, most likely of different origin, often being included in the same evidence bag. 
Once it was determined that the samples were not required for judicial proceedings, they were 
set aside as part of a wider SCRA monitoring study. Prior to sample uplift, items were reviewed 
by Scottish Prison Service staff to ensure that all personal information present on the seized 
materials or on the packaging was removed or redacted. Samples were uplifted by staff from 
the Police Scotland Drug Expert Witness Unit and transported securely to our laboratory. 
Samples from three of the prisons (prisons 1-3) seized between June 2018 and September 2019 
have been described previously9. Additional samples reported in this study for the first time, 
detailed in the supplementary information (Table S1), include more recently seized papers from 
prison 1 covering samples seized between 26th September 2019 and 18th December 2019 (n=58 
individual papers) and samples from an additional establishment, prison 4 (n=59), which had 
not previously been tested. The external packaging containing many of the seizures from prison 
4 did not include seizure dates but those that did ranged from 6th May 2019 to 28th October 
2019. Additional SCRA infused paper samples (n=9), seized between May and August 2020, 
containing emerging SCRAs not previously detected in Scottish prisons were also included in 
the study. Images of selected seized materials, including adapted e-cigarettes, are provided in 
Section 2 of the supplementary information. 
 
The screening method is detailed in Norman, et al. (2020)9. In brief, samples are extracted by 
ultra-sonication in methanol and are qualitatively analyzed using a 7820A gas chromatograph 
coupled to a 5977E mass spectrometer (Agilent Technologies, Santa Clara, CA, USA). 
Injection mode: 1L sample injection and used a 20:1 split into a 1mm internal diameter 
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deactivated glass liner pre-packed with quartz wool, injection port temperature: 200ºC, carrier 
gas: He, flow: 1mL/min. Column: HP-5MS, 0.33m, 0.2 mm x 25m (Agilent Technologies). 
GC oven: 80ºC held for 3min; 40ºC/min to 300ºC held for 3.5 min; total run time: 12 min; 
transfer line: 295ºC. The mass spectrometer operated in electron ionization (EI) mode. 
Ionization conditions: 70eV in full scan mode (50–550 Da), ion source: 230ºC, quadrupole: 
150ºC. Any substances observed within the obtained GC-MS spectra were identified by 
comparing their retention time and mass spectra to reference standards of known origin where 
available, and by comparison to NIST14, SWGDRUG (v3.5), and Cayman Chemicals 
(versions v04262019, v09112019 and v09222020) mass spectral libraries with a minimum 
acceptable reverse match value of 850. Orthogonal confirmatory analysis was carried out using 
a Xevo Ultra Pressure Liquid Chromatography-Photodiode Array-Quadrupole Time of Flight-
Mass Spectrometer (UPLC-PDA-QToF-MS; Waters Corporation, Milford, MA, USA). The 
methanol extracts used for GC-MS analysis were diluted 100-fold in 50:50 ultrapure 
water/acetonitrile prior to analysis. Mobile phases used were (A) LC-MS grade water with 0.1 
% formic acid (V/V %) and (B) acetonitrile with 0.1 % formic acid (V/V %). The gradient used 
was 50:50 A:B from 0.0-4.0 min, 25:75 A:B from 4.0-5.0 min, 5:95 A:B from 5.0-5.99 min 
and 50:50 A:B from 6.0-7.0 min. Flow rate was 0.5 mL/min and 1 L of sample was injected 
onto an ethylene bridged hybrid (BEH) C18 column (50  2.1 mm, 1.7 m particle size;  Waters 
Corporation, Milford, MA, USA). The QToF was operated in positive ionization mode with a 
source temperature of 120 ºC, a desolvation temperature at 500 ºC and a capillary voltage at 
2.25 kV. ToF-MS analysis for the high-resolution determination of molecular mass was carried 
out with a collision energy at 6 V, with a scan range of 100-1000 Da. Mass error of the 
measured accurate mass from theoretical monoisotopic mass was required to be  <10ppm and 
the UV spectra were compared with reference standards of known origin, where available. 
MS/MS spectra were obtained from selected parent ion fragmentation using collision energies 
between 10 and 30 V for further structural confirmation (scan range 100-500 Da). The GC-MS 
and UPLC-PDA-QToF-MS results for many of the samples provided in this study have been 
reported previously9. Sample details, GC-MS and UPLC-PDA-QToF-MS data from samples 
not previously reported are provided in the supplementary information (Table S1). ITMSTM 
data for all samples analyzed in this study are provided in in the supplementary information 
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2.3. Reference Standards 
Cumyl-4CN-BINACA (5), 5F-Cumyl-PEGACLONE (7), (S)-ADB-FUBINACA (8), PB-22 
(QUPIC) (9), FUB-PB-22 (10), (S)-5F-ADB-PINACA (11), (S)-5F-AMB-PINACA (5F-
AMB) (12), and (S)-ADB-CHMINACA (MAB-CHMINACA) (13) reference standards were 
obtained from Chiron, Trondheim, Norway as 1 mg/mL solutions in methanol. Reference 
standards for (S)-5F-MDMB-PICA (1) (>98.7% purity); (S)-4F-MDMB-BINACA (2) (99.7% 
purity); (S)-MDMB-4en-PINACA (5-cl-adb-a) (3) (98.6% purity); (S)-5F-MDMB-PINACA 
(4) (99.6% purity); (S)-AMB-CHMICA (MMB-CHMICA) (6) (99.6% purity); (S)-AB-
CHMINACA (14) (>99% purity); (S)-AMB-FUBINACA (MMB-FUBINACA, FUB-AMB) 
(15) (>98% purity); (S)-AMB-4en-PICA (MMB-022, MMB-4en-PICA) (16) (99.7% purity); 
(S)-MDMB-4en-PICA (17) (>99.7% purity); (S)-MDMB-FUBINACA (18) (>99.9% purity); 
and (S)-AB-FUBINACA (19) (99% purity) were obtained via in-house synthesis as detailed 
previously5,39. 5F-PB-22 (5F-QUPIC) (20) (99% purity) and (S)-MDMB-CHMICA (21) (99% 
purity) were synthesized and supplied by the Sutcliffe Group at Manchester Metropolitan 
University, Manchester, UK. All reference standards were analyzed by GC-MS prior to 
ITMSTM testing. 
 
2.4. ITMS Testing Procedure 
Three Itemiser® 3E (Rapiscan Systems Limited, Surrey, UK) and one Itemiser® 4DN (Rapiscan 
System Limited, Surrey, UK) were used during the study. Both models are ion trap mobility 
spectrometers (ITMSTM). While the overall mechanism of detection is the same as IMS, 
ITMSTM does not have a shutter grid, but instead pulses the ions from a field free ionization 
chamber into the drift tube where the ions are guided to the detector by an electric field. 
Removing the shutter grid, commonly used in other instruments, is reported to eliminate the 
associated loss of ions and can improve sensitivity33. The Itemiser® 4DN uses a photoionization 
source with an auto calibrating UV lamp whereas the Itemiser® 3E uses chemical ionization 
with a radioactive 63Ni source. The “narcotics” factory operating method was used with a 
detector temperature of over 200ºC and desorber temperature of 235ºC. For each sample, the 
4DN produces multiple datasets, denoted Region 0 and Region 1, for proprietary algorithm 
evaluation.  
 
The instruments were received loaded with the drug reference library supplied and maintained 
by the instrument manufacturer, tailored to the prison drug detection market. These libraries 
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are updated at regular intervals as new, relevant, compounds are identified in monitoring 
programmes. The current library, as used in this study, provides identification data and system 
alarm criteria for nine SCRA compounds (“spice” alarms) known to previously have been or 
to be currently circulating in UK prisons. The “spice” alarms are derived from the analytical 
data produced by the instrument manufacturer. The alarm criteria differ from one another in 
terms of the SCRA drift time calculated from the mean of multiple analyses within and between 
instruments across a range of concentrations, the width (in ms) of the detection windows, and 
alarm peak thresholds related to the detector response to specific compounds across a range of 
concentrations. The library also includes other operationally relevant substances, including 
diamorphine (heroin), cocaine, buprenorphine, and tramadol whose drift times do not overlap 
with the main SCRA detection window (8.8-9.8 ms). For security reasons these details and 
information on the full list of substances included in the operational prison testing library are 
not disclosed in this study. The drug reference libraries used on the instruments in this study 
are identical to those used operationally in UK prisons allowing the evaluation of the 
effectiveness of the instruments in an operationally valid manner. 
 
2.4.1 Determination of instrument selectivity 
The selectivity of the ITMSTM test systems was assessed by determining the drift times of a 
wide range of SCRAs across several structural classes, including the most prevalent 
compounds at the time the study was conducted9, as well as emerging and prophetic 
compounds, AMB-4en-PICA (16) and MDMB-4en-PICA (17), which had not yet been 
detected in our prison monitoring study but have the potential to enter the market and for which 
in-house synthesized reference standards were available. To study the variation of drift time 
within two closely related structural classes, the largest number of SCRAs included were 
valinate- or tert-leucinate-indole- or indazole-3-carboxamides. For all analytes, drift times 
were recorded for SCRAs across a wide range of analyte loading masses (0.5 to 1000 ng on 
sample trap). The sample traps were prepared by pipetting SCRA solutions in methanol onto 
clean sample traps that had been previously desorbed and run as blank samples on the ITMSTM 
instruments.  The solvent was allowed to evaporate before the sample trap was inserted into 
the instrument thermal desorber sampling unit. The preparation of the SCRA loaded sample 
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Calculation of Reduced Mobility Values 
Reduced mobility values (K0) are a qualitative indicator of the identity of a gas phase ion based 
on the velocity of the ion in a drift/buffer gas under the influence of a homogeneous electric 
field. Ideally, these values should be constant for a given compound in a given drift gas, but in 
practice they have been found to vary, with the variations being attributed to instrumental 
design variations and the use of different experimental conditions, such as temperature and 
electric field40. K0 values were calculated similarly to that described in Verkouteren, et al. 
(2020)41. For each compound, the average K0 value was determined from K0 values calculated 
from replicate analyses of SCRAs across a range of sample loads (0.5-1000 ng). The K0 value 
was calculated with Equation 1 using the drift time of the sample (td), drift time of cocaine 
(td
coc), and the K0 of cocaine (K0
coc) where K0
coc = 1.160 cm2 V-1 s-1. Cocaine was used as the 




coc) / td          Equation 1 
 
During calibration of the Itemiser® 3E, the system corrects the drift time of cocaine to always 
be 7.945 ms, recalculating all subsequent drift times relative to this value. Therefore, for the 
calculation of the K0 values on these systems, td
coc was always 7.945 ms. For the Itemiser® 
4DN, the drift time of cocaine varies with each calibration, so the drift time of cocaine from 
the external calibration performed before each set of samples was used as the td
coc in the 
calculation of the K0 values for those samples. The values are provided in the supplementary 
data. 
 
2.4.2 Determination of instrument sensitivity 
To estimate instrument limit of detection (LOD) and determine the linearity of instrument 
response, sample traps were loaded with different SCRAs at a variety of loading masses (0.5 
to 1000 ng) as described previously. LODs were determined for 4F-MDMB-BINACA (2), 
MDMB-4en-PINACA (3), Cumyl-4CN-BINACA (5), Cumyl-PEGACLONE (7), AB-
CHMINACA (8), AMB-FUBINACA (9), 5F-PB-22 (10), MDMB-CHMICA (11), and AMB-
4en-PICA (12) to represent a range of SCRA structural classes. Each SCRA at each loading 
mass was analyzed in triplicate on all five instruments (two 4DN systems used during this 
analysis). A quadratic regression curve of the average peak heights for each tested 
concentration was determined for each instrument and the LOD was estimated from either the 
curve (calculated LOD, cLOD) or from the instrument response to traps containing known 
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masses of analyte (observed LOD, oLOD). The firmware on the instruments does not enable 
the signal to noise ratio to be obtained from the plasmagram. The number of points used to 
construct the curve varied depending on the concentration above which the detector response 
plateaued. 
 
2.4.3. Determination of instrument suitability using seized paper samples  
For the analysis of seized paper samples previously analyzed by GC-MS, the blank sample trap 
was first inserted into the instrument to ensure that it was contamination free and to act as a 
negative control for the sample to be tested. The clean sample trap was rubbed along the surface 
of the sample with two fingers applying pressure from the back. Papers and card for testing 
ranged from a few cm2 up to A4 size (21.0 x 29.7cm) and so trap loading is likely to have 
varied considerably. The sample trap was inserted into the thermal desorption sampling port of 
the instrument for analysis. Samples taken from each seized paper sample were run on one of 
each type of instrument (Itemiser® 3E or Itemiser® 4DN). Multiple instruments of the same 
type (three Itemiser® 3E and two Itemiser® 4DN) were used to determine the field accuracy 
rate for each model rather than one specific instrument. This reflects the practice of the 
manufacturer to use multiple instruments when setting up system libraries and substance 
alarms, capturing any system variability between instruments of the same design.  The 
approach to analyse seized samples also reflects the use of different instruments across multiple 
prison sites testing papers infused with the same SCRAs, and thus ensuring relevance to field 
testing practice. If the ITMSTM result differed from the GC-MS result on a particular system, 
the sample was run on a second instrument of that type (e.g. Itemiser® 3E or Itemiser® 4DN) 
to verify the result and ensure the discrepancy was not due to a sampling or instrument error . 
The instrument used, drift time, peak height, and alarm identification were recorded for each 
sample analysis and are provided in the supplementary information (Table S6.1 and S6.2). 
 
3. Results and Discussion 
 
3.1 Instrument Selectivity  
Ideally, from an intelligence and evidential viewpoint, a benchtop IMS screening instrument 
for the analysis of suspected SCRA-infused items would be able to distinguish individual 
SCRA compounds; differentiate SCRAs from other sample components and other drugs likely 
to be present in samples to avoid false positives; and be sensitive enough and have an up-to-
date library to avoid false negatives. From an operational viewpoint, however, the avoidance 
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of false positives and negatives is more important than unambiguous compound identification. 
It is advantageous if all SCRA compounds provide similar results (e.g. drift times, K0, and 
sensitivity) and are easily distinguished from other non-SCRA substances with little overlap in 
drift times. 
 
Average drift times and K0 values for the 21 tested SCRAs are summarized in Tables 1-3 and 
Figures 2 and 3, and ranged from 5.294-9.742 ms on the Itemiser® 3E systems (n=3) 
corresponding to K0 values of 1.7409–0.9458 cm
2 V−1 s−1 and 5.218-9.699 ms, corresponding 
to K0 values of 1.7664-0.9488 cm
2 V−1 s−1 on the Itemiser® 4DN system (n=1). Data for 
individual instruments are provided in the supplementary information (Tables S4.1 to S4.4). 
No significant effect of analyte loading mass on drift times, and therefore K0, was observed. 
 
We have not disclosed the specific “spice” alarms generated by each of the SCRA reference 
standards analyzed in this study; the compounds used to produce the library entries; or which 
SCRAs do not generate an alarm in the current libraries. Disclosure of such information is 
deemed a security risk.  
 
The Itemiser® 3E systems in use in Scottish prisons were able to detect all of the tested 
reference compounds (e.g. produce a measurable peak on the plasmagram), irrespective of 
whether they generated an alarm or not. 15 of the 21 SCRA reference standards tested generated 
an alarm against the current factory set alarms whilst six did not. For the Itemiser® 3E, of the 
21 SCRAs tested, 14 compounds generated system “spice” alarms and 5F-Cumyl-
PEGACLONE (7) alarmed for “tramadol.” The “tramadol” alarm simply indicates that 5F-
Cumyl-PEGACLONE (7) has a similar drift time to the opioid tramadol on the system, a 
reminder that these instruments are essentially advanced presumptive test systems. The 
libraries present are prepared by the manufacturer in the context in which the instruments are 
used, i.e. they only contain substances commonly detected in prisons. The libraries can be 
adapted as required at the local and global level as drug markets and individual substance 
prevalence changes. Five of the six SCRAs which did not generate an alarm had drift times 
within the typical SCRA detection window (8.8-9.8 ms). In an operational context, if these five 
substances were to appear in case samples, trained staff would identify them as being indicative 
of the presence of an unknown SCRA. Samples would be submitted for further laboratory 
testing to confirm or refute the presence of a new SCRA or other substance of interest and 
substance detection libraries updated as required.  
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For the Itemiser® 4DN instruments, 18 of the 21 tested SCRA reference standards produced a 
system alarm. Fourteen of these were the same as those generated on the Itemiser® 3E systems 
whilst four compounds generated different alarms. The two systems use significantly different 
substance detection algorithms. The Itemiser® 3E algorithm is relatively simple and often uses 
a single drift time window (normally in the positive ionization mode for SCRAs) in 
combination with a peak area threshold. If the drift time of a substance analyzed on the 
Itemiser® 3E falls within a specific substance library detection window with a peak area above 
the alarm threshold, it will produce a substance alarm. The Itemiser® 4DN algorithm is more 
complex and its proprietary nature does not permit further investigation in this study. The 
remaining three SCRAs tested did not generate “spice” alarms on the 4DN with its current 
settings. Two of these, Cumyl-4CN-BINACA (5) and 5F-Cumyl-PEGACLONE (7), did not 
generate identifiable peaks on the plasmagram. Cumyl-4CN-BINACA (5) has only been 
detected once in Scottish prisons to date, as a minor component with three other SCRAs in an 
infused paper; and 5F-Cumyl-PEGACLONE (7) has never been detected9. These SCRAs have 
been more prevalent in other jurisdictions, in particular in Germany42. It is important to note 
that these compounds do generate identifiable peaks on the plasmagram of the Itemiser® 3E 
systems and would be detected in submitted samples if present.  
 
Overall, drift times were clearly influenced by structural class. All sixteen valinate- and tert-
leucinate-indole- or indazole-3-carboxamide class SCRAs tested produced drift times between 
8.8 and 9.8 ms, the two SCRAs containing a cumyl moiety produced drift times between 7.0 
and 7.5 ms on the Itemiser® 3E, and the three SCRAs belonging to the quinolinyl indole-3-
carboxylates class (PB-type compounds) produced drift times between 5.2 and 5.4 ms. For the 
Itemiser® 3E systems (Table 1 and Figure 2), 5F-Cumyl-PEGACLONE (7) had the least drift 
time variability (0.030 ms range) and Cumyl-4CN-BINACA (5) the most (0.247 ms range). In 
the instrument substance library, which determines the results required to give a system alarm, 
most compounds have a detection window range of 0.080 ms. As can be seen in Table 3 and 
Figure 3, there was some variability in drift time on the Itemiser® 4DN systems for all the 
compounds, with AMB-FUBINACA (15) (long) showing the least variability (0.069 ms) and 
AB-CHMINACA (8) showing the most variability (0.232 ms) in Region 0 and 5F-PB-22 (20) 
showing the least variability (0.038 ms) and AMB-4en-PICA (16) showing the most variability 
(0.385 ms) in Region 1. Not all of the compounds are included in Figure 3 because there were 
only three data points available, however all data is provided in Table 2. 
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The average K0 values for all SCRAs tested in this study are shown in Table 3 and are compared 
to available literature values. Data for individual instruments is provided in the supplementary 
information (Table S4.1 and S4.2). Due to the general user interface (GUI) / software available 
on the Itemiser® instruments, the resolution between compounds cannot be directly calculated; 
instead the resolution between compounds can be more generally discussed using the 
differences between K0 values of two compounds. According to the UNODC “Recommended 
Methods for the Identification and Analysis of Synthetic Cannabinoid Receptor Agonists in 
Seized Materials” 34, IMS cannot reliably discriminate between compounds with differences in 
K0 values of less than 0.025 cm
2 V-1 s-1. Metternich et al (2019) determined that to obtain a 
resolution of 0.75 between analyte peaks, there needs to be a > 0.15 ms and > 0.013 cm2 V-1 s-
1 difference in drift time and reduced mobility value respectively, between the analyte peaks35. 
For full baseline resolution (Rs = 1.5) the difference had to be > 0.35 ms and > 0.024 cm2 V-1 
s-1. In our study, the mean K0 values of 4F-MDMB-BINACA (2) and MDMB-4en-PINACA 
(3) differ by 0.0070 cm2 V-1 s-1 and so cannot be reliably distinguished and both alarmed as 
“spice 9.”  The 95% confidence intervals of AB-CHMINACA (14) and MDMB-4en-PINACA 
(3) overlapped on both the 3E and Region 1 of the 4DN. This is not deemed problematic in 
seized samples as AB-CHMINACA (14) has not been detected in any seized papers from 
Scottish prisons since the start of sample collection (June 2018) and was controlled by The 
People’s Republic of China in 2015 and so is likely to have disappeared soon after from the 
illicit market43,44. In addition, the alarm for AB-CHMINACA (14) is typically turned off for 
in-field operations and in the event that AB-CHMINACA (14) reappears, it would be picked 
up with a “spice 9” alarm.  
 
The value of 0.0250 cm2 V-1 s-1 is also important to consider when analyzing the range of K0 
values calculated for one compound. Ideally, the K0 values for one compound should not have 
a range greater than 0.0250 cm2 V-1 s-1 (mean K0  0.0125 cm
2 V-1 s-1) or it could potentially be 
discriminated as two separate compounds by the instrument. This is important because if the 
instrument can discriminate between two samples of the same compound, it could lead to 
misidentifications or false negatives. On the Itemiser® 4DN system, the range of K0 values was 
less than 0.0250 cm2 V-1 s-1 for all compounds, except 5F-PB-22 in Region 0, AMB-4en-PICA 
(16) in Region 1, and AB-CHMINACA (14) in both regions. These three compounds had high 
drift variability (see supplementary information for additional instrument-specific data), with 
drift time standard deviations 4-20 times greater than for the other compounds. Potential 
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explanations for the wide drift time range include the possibility of a partial breakdown of the 
substances during the sample desorption and ionization process and the formation of multiple 
adducts with different but unresolved drift times. As the sample desorption settings and 
ionization chamber settings are not user adjustable it was not possible to explore this further in 
this study. 5F-PB-22 and AB-CHMINACA are historical SCRAs that have not been detected 
in Scottish prisons since the start of the current monitoring program in June 2018, AMB-4en-
PICA has not yet been detected, and Itemiser® 4DN systems are not yet in use in Scottish 
prisons. 
 
On the Itemiser® 3Es, the range of K0 values were less than 0.0250 cm
2 V-1 s-1 for all 
compounds, except for Cumyl-4CN-BINACA (5), with a range of 0.0446 cm2 V-1 s-1 across all 
instruments. This large range is likely due to a difference in the performance of Instrument 1 
compared to Instrument 2 and 3 (see supplementary data). The K0 value of Cumyl-4CN-
BINACA (5) on Instrument 1 is different enough from that of the other instruments that it 
would be distinguishable as a separate compound and since all instruments share the same 
substance library, this much variability between instruments could lead to misidentifications or 
false negatives. The reason for the difference in K0 values for one compound out of the 21 
SCRAs tested on one of the three Itemiser® 3E systems tested is unknown. When library entries 
are created by the instrument manufacturer, multiple instruments are used to generate the 
substance drift time and drift time detection window. In an ideal situation, given the results 
obtained, Cumyl-4CN-BINACA (5), could be tested on a larger number of instruments to 
determine whether or not the K0 value obtained on Instrument 1 was an outlier or if the data is 
indicative of greater inherent drift time variability for this substance. In the latter situation, the 
substance drift time detection window would be widened to ensure that any samples containing 
this SCRA would fall within the detection window and generate a system alarm. 
 
Yanini, et al. (2018) reported a K0 value for Cumyl-4CN-BINACA (5) of 1.022
38, 0.2682 cm2 
V−1 s−1  lower than the K0 value found on the Itemiser
® 3E in this study, and a K0 value for 
AMB-CHMICA (6) of 0.968, 0.0387 cm2 V−1 s−1 lower than that found on the Itemiser® 3E in 
this study. In this study, 5F-PB-22 (20) and PB-22 (9) had much higher K0 values (1.7400 and 
1.7409 respectively) than previously reported (0.9995 and 0.9917 respectively)35 on 
instruments of a different design. K0 values for valinate- and leucinate-indazole- and indole-3-
carboxamides, AB-CHMINACA (14), AB-FUBINACA (19), AMB-FUBINACA (15), 
MDMB-CHMICA (21), 5F-AMB-PINACA (12), and 5F-MDMB-PINACA (4) were within 
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0.0250 cm2 V−1 s−1 of previously reported values. This indicates that the relatively large 
differences observed for the K0 values generated by different manufacturer’s IMS systems 
(Smiths Detection IONSCAN and Rapiscan Systems Itemiser® 3E) for Cumyl-4CN-BINACA 
(5), PB-22 (9), and 5F-PB-22 (20) are related to instrument design features (e.g. electric field 
strength or system temperatures) and/or differential adduct formation in the ionization 
chamber, the investigation of which is outside the scope of this study. All previous published 
IMS studies involving SCRAs34-38 have been carried out using IONSCAN systems. This is the 
first study to report SCRA data generated on Rapiscan Itemiser® systems and therefore the first 
time this difference in K0 has been noted. Whilst the difference in K0 values between the 
different systems is of scientific interest and worthy of further investigation, the finding has no 
operational impact. Substance libraries are generated independently by instrument 
manufacturers and are not shared across different instrument suppliers. 
 
K0 values have previously been reported for a range of NPS, including SCRAs
34–38,41, and can 
often be correlated with molecular mass. A strong inverse relationship between K0 and analyte 
molecular mass has previously been demonstrated for fentanyl and fentanyl analogues41, 
phenethylamines34, and SCRAs38. All available K0 data for SCRAs from previous studies
34–38 
have been combined with the averaged K0 data from the Itemiser
® 3E instruments used in this 
study and plotted against molecular mass (Figure 4a). Although there is an apparent inverse 
relationship between reduced mobility and molecular mass for many SCRAs, the relationship 
may be class specific. If data for cumyl-type compounds and quinolinyl (PB-type compounds)  
are removed, the inverse relationship becomes clearer for the remaining compounds from all 
studies (Figure 4b; K0 = -0.0014 (Molecular Mass) + 1.5136; R
2 = 0.6974)  and this study  
(Figure 4c; K0 = -0.0013 (Molecular Mass) + 1.4790; R
2 = 0.5447).  
 
Although the currently most prevalent valinate- and tert-leucinate-indole- and indazole-3-
carboxamide SCRAs have drift times between 8.8-9.8 ms referred to operationally as the 
“typical SCRA drift time window,” SCRAs belonging to markedly different compound classes 
e.g. -carboline (e.g. Cumyl/5F-Cumyl PEGACLONE) and quinolinyl compounds (e.g. PB-
type SCRAs) may have drift times outside of this window. This clearly demonstrates the need 
to couple operational IMS scanning of mail and other items for SCRAs with a more detailed 
seized sample ‘dip’ sampling and rapid laboratory analysis program, rapid information sharing, 
up-to-date training, and close engagement with national and international early warning 
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systems. This ensures up-to-date local intelligence on circulating drugs is maintained and IMS 
scanning systems remain effective. 
 
3.2 Instrument Sensitivity  
Although IMS systems are used for presumptive screening rather than in an evidential context, 
and there is no suggestion that IMS systems should be used for quantitative analysis, it is useful 
to determine their detection limitations. IMS systems are often used to detect trace and ultra-
trace levels of drugs in security settings such as airports and therefore need to be highly 
sensitive; however, SCRAs, although highly potent psychoactive substances, are often present 
at much higher concentrations in infused papers seized in prisons. Previous work by our group 
has shown that SCRA concentrations in infused papers in Scottish prisons range from <0.05 to 
1.17 mg/cm2 paper9.  SCRAs representing a range of market-relevant structural classes were 
selected to study instrument quantitative response and estimate the limit of detection (LOD) 
for each SCRA compound as expressed by mass of analyte on the sample trap. It is important 
to note that the mass of analyte on the sample trap cannot be directly compared to the 
concentration of SCRAs in infused papers because it is not known how much of the analyte is 
collected by the sample trap during sampling. Additionally, any matrix effects due to other 
substances present on the papers (inks, waxes etc) being transferred to the sample trap cannot 
be quantified as the papers sampled are highly variable and the relative recovery efficiencies 
of the materials present is unknown.  
 
The average detector response for the selected SCRA compounds across the tested analyte 
mass range for all three Itemiser® 3E instruments is provided in Figure 5. The replicate data 
(n=3) for each of the SCRA masses from all three Itemiser® 3E instruments (n=9 in total) is 
provided in the supplementary information (Table S5.1 and S5.2 and Figure S5.1-3). For all 
SCRAs there is a non-linear (quadratic) increase in instrument response over a limited analyte 
mass range until the detector response plateaus. The reason for this plateauing may be two-
fold: saturation of the ionization process (there is only so much ionization that can occur in the 
ionization chamber) or saturation of the detector. Metternich, et al. (2019) reported a linear 
increase for the IONSCAN600 IMS instrument over a very limited loading mass range (0.7-
3.6 ng SCRA)35 but did not report response plateauing although this is likely to have occurred. 
Armenta, et al. (2014) and Gwak, et al. (2015) also reported a linear increase for the 
IONSCAN-LS and IONSCAN 400B across very limited loading mass ranges of 0.1-1 ng 
SCRA and 0.05-3 ng SCRA, respectively without any report of response plateauing36,37. For 
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the 3E and 4DN, an approximate quadratic increase in detector response for all compounds was 
observed prior to detector response plateauing. Although only a small number of data points 
were available for most SCRAs in this quadratic response region, quadratic curves were fitted 
and the curves, R2 values, and estimates of the instrument LOD (observed LOD, oLODs) and 
the LOD calculated from the quadratic line of best fit (calculated LOD, cLODs) are provided 
in the supplementary information. oLODs are displayed as a range of concentrations from the 
last sample loading mass to be detected to the first loading mass that was not detected (peak 
height of 0). For the Itemiser® 3E instruments, the cLODs ranged from 0.5 to 12.9 ng, whereas 
the oLODs ranged from 0.5 to 100 ng. AB-CHMINACA (14) had the highest LODs, calculated 
by either method. LODs were found to vary to a relatively small extent between the instruments 
used in this study. 
 
For the Itemiser® 4DN instruments, cLODs ranged from 8.5 to 100.0 ng and 21.1 to 100.0 ng, 
for Region 0 and 1 data respectively, and the oLODs ranged from 5 to 500 ng and 20 to 1000 
ng, respectively. Overall the data indicates that Region 0 has better sensitivity than Region 1, 
while Region 1 was found to have better selectivity. Since the region used in the detection of a 
compound can be dictated in the substance library, the preference for improved selectivity or 
sensitivity is likely to be customized for each compound on this instrument. It is difficult to 
compare the responses of the two models as the Itemiser® 4DN instrument uses a more 
advanced proprietary algorithm for compound detection and identification than the Itemiser® 
3E. However, the 3E had lower LOD values than the 4DN for all compounds although the 
difference is unlikely to be of operational significance, considering the SCRA concentrations 
present in infused papers circulating in prisons. Previous studies using Smiths Detection 
IONSCAN-LS, IONSCAN 400B, and IONSCAN600 have reported lower limits of detection 
for NPS but have used different calculation methods and calibration ranges. Armenta et al. 
(2015) report LODs ranging from 0.02-0.05 ng using a five point calibration over a 0.1-1 ng 
linear calibration range36;  Gwak and Almirall (2015) reported LODs ranging from 0.04-0.08 
ng over a calibration range of 0.1-0.5 ng or 0.3-0.34 ng over a calibration range of 50-1500 
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3.3 Qualitative analysis of SCRAs in seized papers from Scottish prisons by GC-MS 
To test the applicability and reliability of the benchtop ITMS systems for the detection of 
SCRAs in infused papers in a controlled manner and confirm the detection of the most 
prevalent SCRAs in circulation in Scottish prisons up to December 2019, samples were first 
sub-sampled and analyzed by GC-MS (and the identifications of any SCRAs present confirmed 
by UPLC-QTOF-MS). A total of 392 paper samples seized from four Scottish prisons were 
qualitatively analyzed by GC-MS. Controlled substances were detected on 189 samples; 182 
(46%) samples were positive for one or more SCRAs, and controlled drugs other than SCRAs 
were detected in 7 samples. Of those testing positive for SCRAs, 46 contained 4F-MDMB-
BINACA (2); 44 contained 5F-MDMB-PICA (1);  38 contained 5F-MDMB-PINACA (5F-
ADB) (4); 14 contained MDMB-4en-PINACA (3); 3 contained AMB-FUBINACA (9); and 1 
contained AMB-CHMICA (6), on their own. Mixtures of SCRAs were detected on 36 paper 
samples; 18 with MDMB-4en-PINACA (3) and 4F-MDMB-BINACA (2); 9 with MDMB-4en-
PINACA (3), 4F-MDMB-BINACA (2), and 5F-MDMB-PICA (1); 5 with 4F-MDMB-
BINACA (2) and 5F-MDMB-PICA (1); and 4 with 5F-MDMB-PINACA (4) and 5F-MDMB-
PICA (1). The qualitative data for prisons 1-3 seized between June 2018-September 2019 
(n=276) as reported in Norman et al. (2020) are compared with the additional data relating to 
samples seized from prison 1 between September 2019 and 18 December 2019 (n=58) and 
samples from prison 4 (n=59) in Figure 6. The data demonstrates the increasing prevalence of 
MDMB-4en-PINACA (2) and 4F-MDMB-BINACA (3) and the decreasing prevalence of other 
SCRAs in the prisons included in the project over the study period. 
 
3.4 Qualitative analysis of SCRAs in seized papers from Scottish prisons by ITMSTM 
Yanini, et al (2019) describe the use of IMS for the detection of eight SCRAs, including 5F-
MDMB-PINACA (5F-ADB) (4), Cumyl-4CN-BINACA (5), and AMB-CHMICA (MMB-
CHMICA) (6) in apparently high purity seized sample powders38. Metternich, et al. (2019) 
reported the detection of 25 SCRAs (9 of which are also included in this study), in different 
matrices, including herbal mixtures, papers, cosmetic products, and liquid food samples.  The  
method was applied to 36 casework samples, 12 of which were positive for SCRAs and only 
one was a SCRA-infused paper35. In this study, 392 seized papers suspected to be infused with 
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Seized paper samples that had been previously analyzed by GC-MS (using approximately 2 x 
1cm2 sub-samples cut from the paper) were analyzed on the Itemiser® 3E and 4DN ITMS 
systems. An overview of the ITMS results in comparison to the GC-MS data is provided in 
Tables 4 and 5. As some samples gave rise to multiple alarms, the total number of alarms in 
Table 5 is not equivalent to the number of samples. In addition, in the event that the ITMS 
result differed from the GC-MS result, the sample was run a second time on a different 
instrument of the same type in order to corroborate the findings. The results were the same in 
both runs in all cases, except two samples for the Itemiser® 3E (FL19/0104 and FL19/0206-A) 
and one sample for the Itemiser® 4DN (FL19/0022-4). For these samples, the data from both 
runs are included in the analysis, so the total sample count for the Itemiser® 3E appears to be 
394 and the total sample count for the Itemiser® 4DN appears to be 393. The complete ITMS 
analytical data for all the samples is provided in the supplementary information (Table S6.1 
and S6.2).  
 
The level of agreement between the ITMS and GC-MS results was similar between the two 
Rapiscan Itemiser® systems tested: 91.1% for the Itemiser® 3E and 92.9% for the Itemiser® 
4DN systems, demonstrating the suitability of their use for the presumptive detection of SCRAs 
in infused papers in prisons. Papers which gave a negative result for SCRAs by GC-MS but a 
positive result on ITMS were investigated further (Table 4).  Often there are several paper 
samples, from different sources and of different visual appearance in a single seizure and these 
are placed in the same evidence bag for testing. Where some of the papers in the evidence bag 
are infused with SCRAs and others are not, cross contamination is likely to occur. In such 
cases, 2 x 1cm2 sub-samples taken for GC-MS analysis could give a negative SCRA result, but 
the same papers, sampled over a larger surface area with the sample trap could pick up enough 
of the SCRA to be detected on the ITMS systems. Taking the factor of cross contamination 
of samples stored together in evidence bags into account, the level of agreement for SCRA 
detection between the ITMS and GC-MS increases to 94.2% and 95.7% for the Itemiser® 3E 
and Itemiser® 4DN, respectively.    
 
The majority of the false negative results observed on both ITMSTM instruments were related 
to samples where only trace amounts of SCRA were indicated by the GC-MS. This in turn 
indicated that the sample likely did not have purposeful addition of the SCRA but that the 
substances were present as a result of coming into contact with SCRA infused papers. When 
 
This article is protected by copyright. All rights reserved. 
the samples were tested using ITMSTM, no SCRAs could be detected. Other false negative 
results had observable peaks on the plasmagram just outside the drift time region for one of the 
“spice” alarms, but would likely have been set aside by trained staff for further analysis. For 
example, sample FL20/215-E had a large peak near the drift range of a “spice 9” alarm on both 
the 3E and 4DN instruments, but it did not alarm (for more information see section 6 of the 
supplementary information). Many of the potential false positives on the Itemiser® systems 
related to alarms for cocaine and buprenorphine. A larger surface area of the paper is sampled 
during ITMSTM analysis than GC-MS and the presence of these compounds is more likely to 
be due to particulate material adhering to the paper surface than materials infused into the 
paper. This means they will be detected on the ITMSTM systems and not the GC-MS method. 
Additionally, buprenorphine has a retention time greater than the GC run time (12 minutes) 
and is not detected in the SCRA screening method. 
 
On the Itemiser® 3E instruments, 185 samples alarmed for one or more SCRAs with a total of 
192 “spice” alarms across all samples tested. The frequency of the recorded peak heights for 
all sample analyses that generated a “spice” alarm on the Itemiser® 3E can be seen in Figure 
7a. Analysis of almost all of the SCRA infused papers sampled resulted in peak heights well 
above the manufacturer configured alarm thresholds (not shown for security reasons) in 
agreement with our previous work showing the relatively high concentrations of the SCRAs 
present9. Of the 192 “spice” alarms generated, only 19 had peak heights below 1000. Of these, 
GC-MS analyses demonstrated that 2 of these samples were found to have only trace amounts 
of SCRA present and 4 were most likely cross-contamination of SCRAs from being stored in 
the same evidence bag with a considerably more concentrated SCRA-positive sample.  
 
On the Itemiser® 4DN systems, 187 samples alarmed for one or more SCRAs with a total of 
210 “spice” alarms across the samples. The frequency of the peak heights for all “spice” alarms 
on the 4DN can be seen in Figure 7b. Almost all of the samples had detector response peak 
heights well above the alarm thresholds with almost 60% of the samples having peak heights 
over 6000 in both Region 0 and Region 1. Of the 210 alarms, there were 29 and 22 samples 
that were below a peak height of 2000 in Region 0 and Region 1, respectively. The “spice 6” 
alarm on the 4DN systems often alarmed incorrectly and over a wide range of drift times 
meaning that there could be an increased chance of false positive detections for this substance. 
The compound used to generate this alarm was first detected in Europe in 2014 and its 
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production and export was controlled by the People’s Republic of China in 201543,44 and this 
compound is now rarely, if ever, detected on the illicit market. 
 
Despite having higher LODs, as estimated in this study, compared to those reported by other 
studies using different instruments and different LOD calculation methods, both ITMSTM 
models tested here are fit for purpose for the detection of SCRAs at the concentrations 
commonly observed in infused papers in Scottish prisons. The amount of analyte introduced 
into the instrument via the sample trap will inevitably depend on the size of the paper being 
sampled and the method of sampling. The data suggests that the systems are so sensitive, that 
as well as detecting SCRAs in infused papers at relevant concentrations, they may pick up trace 
levels of SCRAs in non-infused samples which have been in contact with or stored with infused 
papers, indicating that in the context of the screening of SCRA infused papers in prisons, 
increased sensitivity is not required. The training of staff in effective sampling and cross-
contamination avoidance is therefore of paramount importance.   
 
The drift time variability of all the “spice” alarms on the Itemiser® 3E is depicted in Figure 8a. 
In the substance library, the “spice 4” alarm is set to have a possible detection window of 0.060 
ms, but in this dataset it had a range of 0.076 ms. The “spice 5” alarm is set to have a possible 
range of 0.060 ms and had an observed range of 0.061 ms in this dataset. The “spice 9” alarm 
had the second highest variability with a range of 0.106 ms, when the substance library is only 
set to have a possible range of 0.080 ms. This is unsurprising as this alarm is detecting both 
4F-MDMB-BINACA (2) and MDMB-4en-PINACA (3) leading to broader, unresolved peaks 
on the instrument plasmagram when SCRA mixtures are present in infused samples, as they 
often are. The “spice 8” alarm had the greatest drift time variability with a range of 0.206 ms, 
which reflects the wider detection window (0.115 ms) for this compound in the substance 
library. This may in part be due to the number of infused paper samples tested that have 
mixtures of 5F-MDMB-PICA (1) and 5F-MDMB-PINACA (4) as these compounds have 
similar drift time detection windows. The Itemiser® 4DN seems to have greater drift time 
variability (Figure 8b) and seems to be more greatly affected by mixtures of SCRAs than the 
3E. This greater variability in drift time on the Itemiser® 4DN is likely at least part of the reason 
for the greater number of incorrect alarm identifications.  
 
Overall, this data indicates that, despite having set detection windows in the substance library, 
both the Itemiser® 3E and 4DN can correctly identify SCRA compounds that lie just outside 
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the detection windows of known compounds. This is due to the ITMSTM systems alarming 
when essentially any amount of a sample peak on the plasmagram falls into a previously set 
alarm threshold, not just when the apex of the peak does. This is beneficial for detecting SCRAs 
with similar, but slightly different drift times within known “typical” drift time ranges, e.g. the 
detection of AMB-CHMICA (6) and MDMB-4en-PINACA (3) on the Itemiser® 3E system on 
alarms developed for other compounds.  
 
This is further demonstrated by the provisional identification of three SCRAs detected in 
Scottish prisons for the first time. In the absence of reference standards for these substances in 
our laboratory at the time of this study, their identification is based on analytical data (GC-MS 
and UPLC-PDA-QToF-MS spectra) and examples of the high resolution mass spectral data are 
provided in section 7 of the supplementary information), as well as comparison with spectral 
libraries and publicly available spectra45–50. 5F-EMB-PICA (22, EMB-2201, ethyl 2-[[1-(5-
fluoropentyl)indole-3-carbonyl]amino]-3-methyl-butanoate) and 4F-MDMB-BICA (23, 
methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3- dimethyl-butanoate) were first 
reported to the European early warning system (EU-EWS) in July 2020, based on seizures on 
the 3rd and 31st March 2020 respectively51,52, and the Response 2 Project by the Hungarian 
Institute for Forensic Sciences, based on seizures on the 20th and 15th of July 2020 
respectively53. These SCRAs were first identified on infused papers seized in three different 
Scottish prisons (prisons 1-3) between May and August 2020. 4F-MDMB-BICA was detected 
as the only SCRA present in 4 samples and 5F-EMB-PICA was detected as the only SCRA 
present in one sample and with MDMB-4en-PINACA in three samples (see Table S1). 5F-
MPP-PICA (24, MPhP-2201, methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3-
phenylpropanoate) was first reported to the EU-EWS and by the Response 2 Project in 201853,54 
and was identified Scotland for the first time in prison 2 in a sample seized in July 2020.  
 
Although these SCRAs are not included in the ITMSTM instrument libraries, they had drift 
times and reduced mobility values close enough to SCRAs in the instrument substance library 
to produce a system “spice” alarm (5F-EMB-PICA (22), drift time = 9.435 ms, K0 = 0.9768 
cm2 V−1 s−1 (n=1); 4F-MDMB-BICA (23), drift time = 9.135 +/- 0.014 ms, K0 = 1.0088 +/- 
0.0016 cm2 V−1 s−1 (n=4) ; and 5F-MPP-PICA (24), drift time = 9.671 ms, K0 = 0.9530 cm
2 
V−1 s−1 (n=1)). Where 5F-EMB-PICA was present as a minor component with MDMB-4en-
PINACA (estimated from GC-MS peak area), the alarm generated was that expected for 
MDMB-4en-PINACA (and 4F-MDMB-BINACA). 
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5F-EMB-PICA had a similar drift time and K0 value to 5F-MDMB-PICA; the only structural 
difference between the two compounds (Figure 1) is the presence of an ethyl ester on the 
“linked group” of the former and a methyl ester in the latter. 4F-MDMB-BICA had a similar 
drift time to 4F-MDMB-BINACA as the only structural difference is that the former has an 
indole “core” group and the latter an indazole “core” group. It is suggested that these minor 
structural changes have little effect on the ion mobility properties and therefore drift times. The 
drift time for 5F-MPP-PICA, which has a benzyl moiety in the “head” group, is similar to the 
library entry for 5F-AKB48 (5F-APINACA, data not shown), the latter SCRA having an 
adamantyl moiety on the “head” group.  
 
4. Conclusion 
The Rapiscan Itemiser® 3E and Itemiser® 4DN systems were evaluated for their reliability to 
rapidly detect SCRA infused papers in prisons in an operationally relevant context. Our 
analysis has confirmed that both instrument types were effective with an agreement of up to 
95% with laboratory-based GC-MS analysis. The Itemiser® 3E was found to be better for use 
in the detection of SCRAs due to its ability to detect cumyl compounds (Cumyl-4CN-BINACA 
and 5F-Cumyl-PEGACLONE), unlike the Itemiser® 4DN with its current detection settings. 
There were some inconsistencies in the K0 values between this study and those reported in 
previously published studies, which is likely due to differences in the electric field strength or 
temperature between different manufacturers’ instruments. In particular, compounds not in the 
most prevalent valinate- and tert-leucinate-indazole and indole SCRA classes (e.g. 5F-PB-22, 
Cumyl-4CN-BINACA, and 5F-Cumyl-PEGACLONE) had considerably lower drift times 
compared to what is operationally often referred to as the SCRA drift time window of 8.8-9.8 
ms. 
 
As observed in this study, any new SCRAs emerging on the market may generate drug 
detection alarms due to their structural similarity to the compounds already in the library. 
However, the importance of training operational, non-scientific staff in prisons to identify 
significant peaks that do not generate alarms, rather than simply responding to pre-set alarms, 
has been highlighted. To keep SCRA detection libraries on IMS/ITMSTM systems up to date it 
is recommended that (i) in situ screening of mail for SCRAs by front-line prison staff using 
IMS/ITMSTM should operate in tandem with effective laboratory-based prison drug monitoring 
programs to rapidly identify and communicate emerging drug threats; (ii) test samples 
suspected of being infused with SCRAs that do not generate an alarm but produce peaks within 
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a typical SCRA detection range should be submitted for priority confirmatory laboratory-based 
testing; (iii) system substance libraries should be updated by trained scientific staff, at a local 
level if possible, to respond to locally emerging drug threats; and (iv) near real-time data and 
intelligence should be shared to maintain drug detection libraries to ensure their operational 
relevance and effectiveness. 
 
Overall, this study found the Rapiscan Itemiser® ITMSTM systems tested to be effective 
instruments for the rapid detection of SCRA infused papers and used effectively, will help 
reduce the supply of SCRAs in the prisons and identify emerging threats. Of course, taking a 
pragmatic view, it is recognized that stopping or reducing one particular supply route by 
introducing routine and effective scanning of mail may cause alternative smuggling methods 
to be developed to supply a well-established prison market. These potential changes in supply 
methods may in turn cause an increase in risk (the law of unintended consequences) and this 
possibility also needs to be considered. 
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Instrument #1 Instrument #2 Instrument #3 Overall  
Mean Range  n Mean Range n Mean Range n mean s.d. n 
Quinolinyl  
indole-3-carboxylates 
PB-22 358.4 5.294 0.001 4 5.281 0.006 4 5.307 0.007 4 5.294 0.011 12 
5F-PB-22 376.4 5.384 0.021 21 5.285 0.035 25 5.295 0.017 22 5.294 0.010 68 
FUB-PB-22 396.4 5.295 0.011 4 5.286 0.017 4 5.305 0.007 4 5.295 0.009 12 
Cumyl indazole-3-
carboxamide 
Cumyl-4CN-BINACA 360.5 7.037 0.034 17 7.205 0.095 21 7.205 0.081 16 7.152 0.081 54 
γ-carbolinone 5F-Cumyl-PEGACLONE 372.5 7.476 0.015 16 7.477 0.022 20 7.485 0.024 18 7.479 0.008 54 
Valinate- and 




AMB-4en-PICA 342.4 8.938 0.026 22 8.951 0.057 24 8.937 0.041 23 8.943 0.012 70 
MDMB-4en-PICA 356.5 9.190 0.008 3 9.191 0.008 3 9.207 0.008 3 9.196 0.009 9 
AB-CHMINACA 356.5 9.126 0.052 13 9.146 0.082 17 9.151 0.052 16 9.142 0.020 46 
MDMB-4en-PINACA 357.5 9.142 0.022 19 9.157 0.029 23 9.146 0.021 18 9.149 0.009 60 
5F-ADB-PINACA 362.5 8.804 0.019 3 8.845 0.025 3 8.877 0.029 3 8.842 0.033 9 
4F-MDMB-BINACA 363.4 9.084 0.038 21 9.085 0.085 28 9.085 0.040 25 9.085 0.014 74 
AB-FUBINACA 368.4 8.994 0.009 3 9.032 0.018 4 9.026 0.012 3 9.019 0.018 10 
AMB-CHMICA 370.5 9.148 0.008 3 9.159 0.013 3 9.157 0.010 3 9.155 0.007 9 
5F-MDMB-PICA 376.5 9.395 0.010 3 9.387 0.026 3 9.388 0.006 3 9.39 0.008 9 
5F-MDMB-PINACA 377.5 9.293 0.004 3 9.317 0.021 3 9.312 0.012 3 9.307 0.013 9 
5F-AMB-PINACA 363.4 9.043 0.010 3 9.072 0.019 3 9.060 0.009 3 9.058 0.014 9 
ADB-FUBINACA 382.4 9.152 0.019 3 9.166 0.071 5 9.189 0.030 3 9.169 0.024 11 
AMB-FUBINACA 383.4 9.291 0.034 21 9.304 0.034 24 9.303 0.046 21 9..299 0.011 66 
ADB-CHMINACA 370.5 9.269 0.023 4 9.305 0.045 4 9.335 0.021 3 9.300 0.032 11 
MDMB-CHMICA 384.5 9.737 0.038 16 9.745 0.024 23 9.743 0.041 21 9.742 0.010 60 
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Region 0 Region 1 




PB-22 358.4 5.257 - 1 5.287 0.02 3 
5F-PB-22 376.4 5.218 0.071 16 5.298 0.004 6 






AMB-4en-PICA 342.4 8.954 0.010 15 8.808 0.146 12 
MDMB-4en-PICA 356.5 9.171 0.03 3 9.007 0.292 3 
AB-CHMINACA 356.5 8.995 0.083 8 8.886 NA 1 
MDMB-4en-PINACA 357.5 9.170 0.019 17 9.167 0.014 14 
5F-ADB-PINACA 362.5 8.801 0.185 3 8.753 0.059 2 
4F-MDMB-BINACA 363.4 9.122 0.017 16 9.120 0.013 14 
AB-FUBINACA 368.4 9.046 0.021 3 9.061 0.007 2 
AMB-CHMICA 370.5 9.155 0.005 3 9.164 0.036 3 
5F-MDMB-PICA 376.5 9.385 0.029 3 9.427 0.020 3 
5F-MDMB-PINACA 377.5 9.241 0.072 3 9.29 0.019 3 
5F-AMB-PINACA 363.4 9.073 0.016 3 9.08 0.004 3 
ADB-FUBINACA 382.4 9.068 0.235 3 9.085 0.042 2 
AMB-FUBINACA (L) 383.4 9.289 0.016 15 9.281 0.013 13 
AMB-FUBINACA (S) 383.4 9.358 0.027 14 9.358 0.016 11 
ADB-CHMINACA 370.5 9.203 0.104 3 9.216 0.069 3 
MDMB-CHMICA 384.5 9.699 0.015 13 9.697 0.010 10 
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Table 3. Average reduced mobility (K0) values for SCRAs analyzed using Itemiser
® 3E and Itemiser® 4DN instruments for all 






Itemiser® 4DN Literature 
values Region 0 Region 1 




PB-22 1.7409 0.0037 0.0102 12 0.0021 1.7514 - - 1 - 1.7403 0.0037 0.0066 3 0.0042 0.9917 [35] 
5F-PB-22 1.7408 0.0032 0.0175 68 0.0008 1.7664 0.0195 0.0682 30 0.0070 1.7387 0.0032 0.0099 10 0.0020 0.9995 [35] 
FUB-PB-22 1.7406 0.0031 0.0105 12 0.0017 1.7513 0.0071 0.0126 3 0.0080 1.7404 0.0028 0.0049 3 0.0031   
Cumyl indazole-
3-carboxamide 
Cumyl-4CN-BINACA 1.2888 0.0147 0.0446 54 0.0039 - - - - - - - - - - 1.022 [38] 






AMB-4en-PICA 1.0306 0.0013 0.0084 70 0.0003 1.0319 0.0038 0.0114 29 0.0014 1.0473 0.0173 0.0434 23 0.0071   
MDMB-4en-PICA 1.0022 0.0010 0.0027 9 0.0006 1.0039 0.0016 0.0033 3 0.0019 1.0217 0.0178 0.0329 3 0.0202   
AB-CHMINACA 1.0081 0.0022 0.0091 46 0.0006 1.0168 0.0112 0.0262 16 0.0055 1.0120 0.0135 0.0312 5 0.0118 0.9975 [35] 
MDMB-4en-PINACA 1.0073 0.0010 0.0042 60 0.0003 1.0043 0.0021 0.0074 35 0.0007 1.0035 0.0012 0.0052 29 0.0004   
5F-ADB-PINACA 1.0423 0.0039 0.0112 9 0.0026 1.0462 0.0126 0.0218 3 0.0142 1.0513 0.0050 0.0071 2 0.0069   
4F-MDMB-BINACA 1.0145 0.0016 0.0096 74 0.0004 1.0068 0.0014 0.0062 31 0.0005 1.0089 0.0017 0.0061 28 0.0006   
AB-FUBINACA 1.0217 0.0021 0.0069 12 0.0012 1.0178 0.0012 0.0024 3 0.0014 1.0155 0.0006 0.0008 2 0.0008 1.0123 [35] 
AMB-CHMICA 1.0067 0.0008 0.0023 9 0.0005 1.0056 0.0003 0.0005 3 0.0003 1.0040 0.0022 0.0039 3 0.0025 0.9680 [38] 
5F-MDMB-PICA 0.9815 0.0009 0.0027 9 0.0006 0.9810 0.0017 0.0030 3 0.0019 0.9761 0.0011 0.0021 3 0.0012   





5F-AMB-PINACA 1.0174 0.0016 0.0046 9 0.0010 1.0148 0.0009 0.0018 3 0.0010 1.0133 0.0002 0.0004 3 0.0003 1.0123 [35] 
ADB-FUBINACA 1.0045 0.0022 0.0066 9 0.0014 1.0154 0.0138 0.0264 3 0.0157 1.0128 0.0033 0.0047 2 0.0046   
AMB-FUBINACA (long) 
0.9910 0.0011 0.0066 66 0.0003 
0.9905 0.0026 0.0097 31 0.0009 0.9887 0.0019 0.0055 27 0.0007 
0.9984 [35] 
AMB-FUBINACA (short) 0.9861 0.0024 0.0109 30 0.0009 0.9844 0.0024 0.0082 24 0.0010 
ADB-CHMINACA 0.9910 0.0034 0.0089 11 0.0020 1.0005 0.0061 0.0113 3 0.0069 0.9984 0.0038 0.0075 3 0.0043   
MDMB-CHMICA 0.9460 0.0009 0.0040 60 0.0002 0.9488 0.0020 0.0070 30 0.0007 0.9477 0.0013 0.0047 23 0.0005 0.9415 [35] 
MDMB-FUBINACA 0.9645 0.0014 0.0036 9 0.0009 0.9609 0.0005 0.0009 3 0.0005 0.9586 0.0007 0.0013 3 0.0008   
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Agreement between ITMS 







Count * % Count * % 
Agree 358 91.1 365 92.9 
-ve ITMS / +ve GC-MS 13 3.3 10 2.6 
+ve ITMS / -ve GC-MS 21 5.4 18 4.6 
Likely cross-contamination 12 3.1 11 2.8 
Other 9 2.3 7 1.8 
 
* Of a total of 392 seized paper samples. 
  
 
This article is protected by copyright. All rights reserved. 
Table 5. Itemiser® 3E and 4DN results for all prison samples in comparison to the GC-MS result. There are only 392 samples, but 407 alarms for the 3E 
because 11 samples had two different alarms, 1 sample had three different alarms, and 2 samples were run on two different 3E instruments with different 

















































No Alarm 183 (50.3%) - - 13 (100%) - 196 (48.2%) 189 (51.2%) - - 10 (100%) - 199 (47.8%) 
Spice 2 - 1 (11.1%) 2 (22.2%) - - 3 (0.7%) - 3 (16.7%) - - - 3 (0.7%) 
Spice 4 3 (0.8%) 1 (11.1%) - - 2 (16.7%) 6 (1.5%) 35 (9.5%) 3 (16.7%) - - 1 (9.1%) 39 (9.4%) 
Spice 5 42 (11.5%) - - - 1 (8.3%) 43 (10.6%) 3 (0.8%) 4 (22.2%) - - - 7 (1.7%) 
Spice 6 - - 1 (11.1%) - - 1 (0.2%) - 8 (44.4%) 1 (12.5%) - - 9 (2.2%) 
Spice 8 46 (12.6%) - - - 4 (33.3%) 50 (12.3%) 66 (17.9%) - 2 (25.0%) - 6 (54.5%) 74 (17.8%) 
Spice 9 81 (22.3%) - 3 (33.3%) - 5 (41.7%) 89 (21.9%) 72 (19.5%) - 2 (25.0%) - 4 (36.4%) 78 (18.8%) 
Sub-Total 355 2 6 13 12 388 365 18 5 10 11 409 
Buprenorphine+ - 1 (11.1%) 3 (33.3%) - - 4 (1.0%) - - - - - - 
Cocaine 8 (2.2%) 1 (11.1%) - - - 9 (2.2%) 4 (1.1%) - 3 (37.5%) - - 7 (1.7%) 
Gabapentin+ 1 (0.3%) - - - - 1 (0.2%) - - - - - - 
Street Heroin+ - 2 (22.2%) - - - 2 (0.5%) - - - - - - 
Tramadol+ - 3 (33.3%) - - - 3 (0.7%) - - - - - - 
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Figure 2. Drift time variation of SCRA data on Itemiser® 3E for (a) valinate- and tert-
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Figure 3. Drift time variation of SCRA data on the Itemiser® 4DN ITMS systems. The 
Itemiser® 4DN provides two datasets for each sample, which are differentiated in the figure 
as Region 0 (black) and Region 1 (red). 12 additional SCRAs were tested, but since there 
were only three replicate analyses of each SCRA, they are not included in this figure; 
however, their data can be found in Table 2. 
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Figure 4. The relationship between reduced mobility and molecular mass (a) all available 
SCRA data from this and published studies, (b) selected SCRA data from this and published 
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Figure 5. Relationship between synthetic cannabinoid receptor agonist sample trap loading 
mass (ng) and mean detector response for three Itemiser® 3E instruments. A line for the 
average alarm threshold is included at a peak height of 500. Lines provided linking data are 
point to point, are shown for illustrative purposes and have no statistical meaning. 
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Figure 6. Summary of qualitative gas-chromatography mass spectrometry data for the SCRAs 
in infused papers from Scottish prisons (a) from prisons 1-3 between June 2018 and 
September 2019 as previously reported by Norman et al., 20206, (b) from prison 1 September 
2019 to 20th December 2019 and (c) from prison 4. Sample information for samples shown 
in (b) and (c) can be found in the supplementary information Table S1. 
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Figure 7. Frequency of analyte peak height for all SCRA alarms for the prison samples on (a) 
the Itemiser® 3E (n = 192) and (b) the Itemiser ® 4DN by detection region (Region 0 
(black), Region 1 (red), n = 210). 
  
 
This article is protected by copyright. All rights reserved. 
 
 
Figure 8. Drift time variability of all SCRA alarms for the prison samples on the (a) 
Itemiser® 3E (n = 191) and (b) the Itemiser® 4DN by detection region: Region 0 (black, n = 
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